{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:04:22Z","timestamp":1792461862238,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.eururo.2017.05.048","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T00:31:07Z","timestamp":1496881867000},"page":"641-649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":200,"title":["Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma"],"prefix":"10.1016","volume":"72","author":[{"given":"Tyler J.","family":"Moss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Beom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader E.","family":"Ezzedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel E.","family":"Mosqueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan A.","family":"Czerniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth P.","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surena F.","family":"Matin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2017.05.048_bib0165","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.05.048_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/em.21756","article-title":"Aristolochic acid nephropathy: harbinger of a global iatrogenic disease","volume":"54","author":"Grollman","year":"2013","journal-title":"Environ Mol Mutagenesis"},{"key":"10.1016\/j.eururo.2017.05.048_bib0175","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.eururo.2012.06.029","article-title":"Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy","volume":"63","author":"Rink","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.05.048_bib0180","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.juro.2010.12.102","article-title":"Upper urinary tract carcinoma in Lynch syndrome cases","volume":"185","author":"Crockett","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.05.048_bib0185","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2017.05.048_bib0190","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2017.05.048_bib0195","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1158\/1078-0432.CCR-14-1215","article-title":"Invasive bladder cancer: genomic insights and therapeutic promise","volume":"21","author":"Kim","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2017.05.048_bib0200","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","article-title":"Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial","volume":"387","author":"Rosenberg","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2017.05.048_bib0205","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.eururo.2017.05.048_bib0210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","article-title":"Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial","volume":"389","author":"Balar","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2017.05.048_bib0215","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.eururo.2015.07.039","article-title":"Genomic characterization of upper tract urothelial carcinoma","volume":"68","author":"Sfakianos","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.05.048_bib0220","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ng.3444","article-title":"Genomic profiling of Sezary syndrome identifies alterations of key T cell signaling and differentiation genes","volume":"47","author":"Wang","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.eururo.2017.05.048_bib0225","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.eururo.2017.05.048_bib0230","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1101\/gr.174789.114","article-title":"Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication","volume":"24","author":"Shinbrot","year":"2014","journal-title":"Genome Res"},{"key":"10.1016\/j.eururo.2017.05.048_bib0235","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.celrep.2015.12.005","article-title":"Ampullary cancers harbor ELF3 tumor suppressor gene mutations and exhibit frequent WNT dysregulation","volume":"14","author":"Gingras","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.eururo.2017.05.048_bib0240","doi-asserted-by":"crossref","unstructured":"Covington K, Shinbrot E, Wheeler DA. Mutation signatures reveal biological processes in human cancer. bioRxiv. http:\/\/doi.org\/10.1101\/036541.","DOI":"10.1101\/036541"},{"key":"10.1016\/j.eururo.2017.05.048_bib0245","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2017.05.048_bib0250","doi-asserted-by":"crossref","first-page":"e1001138","DOI":"10.1371\/journal.pcbi.1001138","article-title":"deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data","volume":"7","author":"McPherson","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.eururo.2017.05.048_bib0255","doi-asserted-by":"crossref","first-page":"12353","DOI":"10.1073\/pnas.0904720106","article-title":"Chimeric transcript discovery by paired-end transcriptome sequencing","volume":"106","author":"Maher","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.eururo.2017.05.048_bib0260","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12014-010-9055-y","article-title":"A technical assessment of the utility of reverse phase protein arrays for the study of the functional proteome in non-microdissected human breast cancers","volume":"6","author":"Hennessy","year":"2010","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.eururo.2017.05.048_bib0325","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.urology.2008.07.042","article-title":"Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study","volume":"73","author":"Fernandez","year":"2009","journal-title":"Urology."},{"key":"10.1016\/j.eururo.2017.05.048_bib0270","doi-asserted-by":"crossref","first-page":"16497","DOI":"10.1038\/srep16497","article-title":"Regulation of iron homeostasis by the p53-ISCU pathway","volume":"5","author":"Funauchi","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.eururo.2017.05.048_bib0275","doi-asserted-by":"crossref","first-page":"48930","DOI":"10.1074\/jbc.M400386200","article-title":"NDRG1 is necessary for p53-dependent apoptosis","volume":"279","author":"Stein","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.eururo.2017.05.048_bib0280","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.eururo.2017.05.048_bib0285","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/hmg\/dds486","article-title":"Oncogenic FGFR3 gene fusions in bladder cancer","volume":"22","author":"Williams","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.eururo.2017.05.048_bib0290","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/cancers7010342","article-title":"Complex of MUC1, CIN85 and Cbl in colon cancer progression and metastasis","volume":"7","author":"Cascio","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.eururo.2017.05.048_bib0295","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/carcin\/bgs228","article-title":"Increased levels of the HER1 adaptor protein Rukl\/CIN85 contribute to breast cancer malignancy","volume":"33","author":"Samoylenko","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.eururo.2017.05.048_bib0300","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1593\/neo.10396","article-title":"A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the ras-ERK pathway","volume":"12","author":"Wakasaki","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.eururo.2017.05.048_bib0305","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0014-5793(02)03188-5","article-title":"CIN85\/CMS family of adaptor molecules","volume":"529","author":"Dikic","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.eururo.2017.05.048_bib0310","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1083\/jcb.201411025","article-title":"CIN85 modulates TGFbeta signaling by promoting the presentation of TGFbeta receptors on the cell surface","volume":"210","author":"Yakymovych","year":"2015","journal-title":"J Cell Biol"},{"issue":"Suppl 6","key":"10.1016\/j.eururo.2017.05.048_bib0315","first-page":"781PD","article-title":"Safety and activity of the pan\u2013fibroblast growth factor receptor (FGFR) inhibitor erdafitinib in phase 1 study patients with advanced urothelial carcinoma","volume":"27","author":"Soria","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2017.05.048_bib0320","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gku1075","article-title":"COSMIC: exploring the world's knowledge of somatic mutations in human cancer","volume":"43","author":"Forbes","year":"2015","journal-title":"Nucleic Acids Res"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283817304888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283817304888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T22:01:05Z","timestamp":1535752865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283817304888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0302283817304888"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2017.05.048","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2017.05.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}